PT  - JOURNAL ARTICLE
AU  - WEN LIU
AU  - MOHAMMED MOULAY
AU  - SASKIA WILLENBROCK
AU  - CATRIN ROOLF
AU  - CHRISTIAN JUNGHANSS
AU  - ANACLET NGENAZAHAYO
AU  - INGO NOLTE
AU  - HUGO MURUA ESCOBAR
TI  - Comparative Characterization of Stem Cell Marker Expression, Metabolic Activity and Resistance to Doxorubicin in Adherent and Spheroid Cells Derived from the Canine Prostate Adenocarcinoma Cell Line CT1258
DP  - 2015 Apr 01
TA  - Anticancer Research
PG  - 1917--1927
VI  - 35
IP  - 4
4099  - http://ar.iiarjournals.org/content/35/4/1917.short
4100  - http://ar.iiarjournals.org/content/35/4/1917.full
SO  - Anticancer Res2015 Apr 01; 35
AB  - Background: Canine prostate cancer represents a spontaneous animal model for the human counterpart. Cells with stem cell-like character are considered to play a major role in therapeutic resistance and tumor relapse. Thus, the identification of markers allowing for recognition and characterization of these cells is essential. Materials and Methods: Expression of 12 stem cell marker genes in the canine prostate cancer cell line CT1258 and spheroid cells generated from these was analyzed by quantitative real-time PCR. In CT1258 and the generated spheroid cells, CD44 and CD133 expression was analyzed by flow cytometry, as well as proliferation and doxorubicin resistance. Results: Integrin alpha-6 (ITGA6) expression and metabolic activity were significantly up-regulated in CT1258-derived spheroid cells, while doxorubicin resistance remained comparable. Conclusion: ITGA6 de-regulation and metabolic activity appear to be characteristic of the generated spheres, indicating potential intervention targets.